跳至主要内容
临床试验/KCT0007043
KCT0007043招募中未知

A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of SGF500 on dry eye

Jeonbuk National University Hospital0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19?(Year) 至 o Limit(—)
性别
All

入选标准

  • 1) OSDI =13 at screening test
  • 2) TBUT=10 or (+) on Fluorescein staining at screening test
  • 3) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

排除标准

  • 1) Patients with a clinically significant disease requiring treatment (i.e., cardiovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
  • 2) Patients with a history of antipsychotic medication use within 3 months prior to the screening examination
  • 3)Patients who have participated in other clinical trials within 3 months prior to the screening examination
  • 4)Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes

研究者

相似试验